Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Weydt

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
The Journal of Clinical Investigation|November 6, 2025
Early brain-wide disruption of sleep microarchitecture in amyotrophic lateral sclerosisChristina Lang, Simon J Guillot, Dorothee Lule, et al.
Human Molecular Genetics|May 15, 2013
PGC-1α is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosisJudith Eschbach, Birgit Schwalenstöcker, Selma M Soyal, et al.
Neurobiology of Disease|November 8, 2016
ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissuesHanna Bayer, Kerstin Lang, Eva Buck, et al.
Frontiers in Neurology|December 3, 2019
Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With NusinersenClaudia D Wurster, Jan C Koch, Isabell Cordts, et al.
Neurological Research and Practice|August 23, 2024
User expectations and experiences of an assistive robotic arm in amyotrophic lateral sclerosis: a multicenter observational studySusanne Spittel, Thomas Meyer, Ute Weyen, et al.
Muscle & Nerve|March 17, 2023
Neurofilament light-chain response during therapy with antisense oligonucleotide tofersen in SOD1-related ALS: Treatment experience in clinical practiceThomas Meyer, Peggy Schumann, Patrick Weydt, et al.
Journal of Alzheimer'S Disease : JAD|July 22, 2017
Novel Blood-Based Biomarkers of Cognition, Stress, and Physical or Cognitive Training in Older Adults at Risk of Dementia: Preliminary Evidence for a Role of BDNF, Irisin, and the Kynurenine PathwayOlivia C Küster, Daria Laptinskaya, Patrick Fissler, et al.
Neurological Research and Practice|April 27, 2025
Motor phenotypes of amyotrophic lateral sclerosis - a three-determinant anatomical classification based on the region of onset, propagation of motor symptoms, and the degree of upper and lower motor neuron dysfunctionThomas Meyer, Matthias Boentert, Julian Großkreutz, et al.
Journal of Neurology|February 22, 2018
The metabolic and endocrine characteristics in spinal and bulbar muscular atrophyAngela Rosenbohm, Susanne Hirsch, Alexander E Volk, et al.
Brain : a Journal of Neurology|September 7, 2014
Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriersAxel Freischmidt, Kathrin Müller, Lisa Zondler, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
The Journal of Clinical Investigation|November 6, 2025
Early brain-wide disruption of sleep microarchitecture in amyotrophic lateral sclerosisChristina Lang, Simon J Guillot, Dorothee Lule, et al.
Human Molecular Genetics|May 15, 2013
PGC-1α is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosisJudith Eschbach, Birgit Schwalenstöcker, Selma M Soyal, et al.
Neurobiology of Disease|November 8, 2016
ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissuesHanna Bayer, Kerstin Lang, Eva Buck, et al.
Frontiers in Neurology|December 3, 2019
Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With NusinersenClaudia D Wurster, Jan C Koch, Isabell Cordts, et al.
Neurological Research and Practice|August 23, 2024
User expectations and experiences of an assistive robotic arm in amyotrophic lateral sclerosis: a multicenter observational studySusanne Spittel, Thomas Meyer, Ute Weyen, et al.
Muscle & Nerve|March 17, 2023
Neurofilament light-chain response during therapy with antisense oligonucleotide tofersen in SOD1-related ALS: Treatment experience in clinical practiceThomas Meyer, Peggy Schumann, Patrick Weydt, et al.
Journal of Alzheimer'S Disease : JAD|July 22, 2017
Novel Blood-Based Biomarkers of Cognition, Stress, and Physical or Cognitive Training in Older Adults at Risk of Dementia: Preliminary Evidence for a Role of BDNF, Irisin, and the Kynurenine PathwayOlivia C Küster, Daria Laptinskaya, Patrick Fissler, et al.
Neurological Research and Practice|April 27, 2025
Motor phenotypes of amyotrophic lateral sclerosis - a three-determinant anatomical classification based on the region of onset, propagation of motor symptoms, and the degree of upper and lower motor neuron dysfunctionThomas Meyer, Matthias Boentert, Julian Großkreutz, et al.
Journal of Neurology|February 22, 2018
The metabolic and endocrine characteristics in spinal and bulbar muscular atrophyAngela Rosenbohm, Susanne Hirsch, Alexander E Volk, et al.
Brain : a Journal of Neurology|September 7, 2014
Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriersAxel Freischmidt, Kathrin Müller, Lisa Zondler, et al.
Pageof 11